Cargando…
Controversies and evidence of hepatic resection for hepatocellular carcinoma()
Symptoms of early hepatocellular carcinoma (HCC) often go unnoticed, so more than half of patients with primary HCC are diagnosed after their disease has already reached an intermediate or advanced stage, or after portal hypertension has appeared. While hepatic resection is widely recognized as a fi...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067978/ https://www.ncbi.nlm.nih.gov/pubmed/27761414 http://dx.doi.org/10.1016/j.bbacli.2016.10.001 |
_version_ | 1782460738364768256 |
---|---|
author | Zhong, Jian-Hong Torzilli, Guido Xing, Hao Li, Chao Han, Jun Liang, Lei Zhang, Han Dai, Shu-Yang Li, Le-Qun Shen, Feng Yang, Tian |
author_facet | Zhong, Jian-Hong Torzilli, Guido Xing, Hao Li, Chao Han, Jun Liang, Lei Zhang, Han Dai, Shu-Yang Li, Le-Qun Shen, Feng Yang, Tian |
author_sort | Zhong, Jian-Hong |
collection | PubMed |
description | Symptoms of early hepatocellular carcinoma (HCC) often go unnoticed, so more than half of patients with primary HCC are diagnosed after their disease has already reached an intermediate or advanced stage, or after portal hypertension has appeared. While hepatic resection is widely recognized as a first-line therapy to treat very early or early HCC, its use in treating intermediate or advanced HCC or HCC involving portal hypertension remains controversial. Here we review PubMed-indexed literature covering the use of hepatic resection for such patients. The available evidence strongly suggests that, as a result of improvements in surgical techniques and perioperative care, hepatic resection can benefit many patients with intermediate or advanced HCC or with HCC associated with portal hypertension. |
format | Online Article Text |
id | pubmed-5067978 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-50679782016-10-19 Controversies and evidence of hepatic resection for hepatocellular carcinoma() Zhong, Jian-Hong Torzilli, Guido Xing, Hao Li, Chao Han, Jun Liang, Lei Zhang, Han Dai, Shu-Yang Li, Le-Qun Shen, Feng Yang, Tian BBA Clin Review Article Symptoms of early hepatocellular carcinoma (HCC) often go unnoticed, so more than half of patients with primary HCC are diagnosed after their disease has already reached an intermediate or advanced stage, or after portal hypertension has appeared. While hepatic resection is widely recognized as a first-line therapy to treat very early or early HCC, its use in treating intermediate or advanced HCC or HCC involving portal hypertension remains controversial. Here we review PubMed-indexed literature covering the use of hepatic resection for such patients. The available evidence strongly suggests that, as a result of improvements in surgical techniques and perioperative care, hepatic resection can benefit many patients with intermediate or advanced HCC or with HCC associated with portal hypertension. Elsevier 2016-10-11 /pmc/articles/PMC5067978/ /pubmed/27761414 http://dx.doi.org/10.1016/j.bbacli.2016.10.001 Text en © 2016 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Article Zhong, Jian-Hong Torzilli, Guido Xing, Hao Li, Chao Han, Jun Liang, Lei Zhang, Han Dai, Shu-Yang Li, Le-Qun Shen, Feng Yang, Tian Controversies and evidence of hepatic resection for hepatocellular carcinoma() |
title | Controversies and evidence of hepatic resection for hepatocellular carcinoma() |
title_full | Controversies and evidence of hepatic resection for hepatocellular carcinoma() |
title_fullStr | Controversies and evidence of hepatic resection for hepatocellular carcinoma() |
title_full_unstemmed | Controversies and evidence of hepatic resection for hepatocellular carcinoma() |
title_short | Controversies and evidence of hepatic resection for hepatocellular carcinoma() |
title_sort | controversies and evidence of hepatic resection for hepatocellular carcinoma() |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067978/ https://www.ncbi.nlm.nih.gov/pubmed/27761414 http://dx.doi.org/10.1016/j.bbacli.2016.10.001 |
work_keys_str_mv | AT zhongjianhong controversiesandevidenceofhepaticresectionforhepatocellularcarcinoma AT torzilliguido controversiesandevidenceofhepaticresectionforhepatocellularcarcinoma AT xinghao controversiesandevidenceofhepaticresectionforhepatocellularcarcinoma AT lichao controversiesandevidenceofhepaticresectionforhepatocellularcarcinoma AT hanjun controversiesandevidenceofhepaticresectionforhepatocellularcarcinoma AT lianglei controversiesandevidenceofhepaticresectionforhepatocellularcarcinoma AT zhanghan controversiesandevidenceofhepaticresectionforhepatocellularcarcinoma AT daishuyang controversiesandevidenceofhepaticresectionforhepatocellularcarcinoma AT lilequn controversiesandevidenceofhepaticresectionforhepatocellularcarcinoma AT shenfeng controversiesandevidenceofhepaticresectionforhepatocellularcarcinoma AT yangtian controversiesandevidenceofhepaticresectionforhepatocellularcarcinoma |